Skip to main content
. 2015 Sep 10;10(9):e0137255. doi: 10.1371/journal.pone.0137255

Table 3. Mesenchymal markers examined by FACS.

Percentage of the cells positive for each MSC marker examined in MSCS at Phases A-C. Average percentage was calculated between the hMSC populations examined.

Marker Population Phase A Phase B Phase C
CD29 hMSC-20176 98% 98% 96%
hMSC-21558 99% 98% 69%
Average 98.5% 98% 83%
CD44 hMSC-20176 99% 99% 95%
hMSC-21558 99% 98% 75%
Average 99% 98.5% 85%
CD45 hMSC-20176 91% 93% 88%
hMSC-21558 98% 97% 64%
Average 95% 95% 76%